6550--Rapid Molecular Testing via Roche Diagnostics Corporation

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 is seeking rapid molecular testing capabilities for SARS COV-2, Flu, and Strep through Roche Diagnostics Corporation. The procurement will be conducted by the Network Contracting Office in Vancouver, Washington, with performance occurring at the Jonathan M Wainwright Memorial VA medical facility in Walla Walla, Washington. This presolicitation notice indicates the government is preparing for a formal solicitation to acquire molecular diagnostic testing equipment and services under product service code 6550 and NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing. The contracting specialist Hector Gonzalez serves as the primary point of contact and can be reached at hector.gonzalez1@va.gov. Interested vendors must submit their responses by September 12, 2025 at 5:00 PM Pacific Time. The evaluation criteria and specific contract requirements have not yet been detailed in this preliminary notice stage.

This procurement opportunity does not utilize any set-aside designations, making it open to all qualified contractors. The presolicitation specifically identifies Roche Diagnostics Corporation as the intended provider for the rapid molecular testing capabilities, suggesting this may be a sole-source or brand-specific requirement. No award values, budget ranges, or contract ceiling amounts have been disclosed at this presolicitation stage. The document does not specify quantities of testing equipment or reagents to be procured, nor does it establish timelines for service delivery or contract performance periods. The solicitation number 36C26025Q0839 will likely be used for the formal solicitation when it is released. Additional details regarding contract scope, technical specifications, and commercial terms are expected to be provided in the forthcoming formal solicitation document.